6 January, 2023Amolyt Pharma announces $138 million Series C financing led by Sofinnova Partners and co-led by Intermediate Capital Group
7 November, 2022Sensorion announces US FDA grants Rare Pediatric Disease Designation to OTOF-GT for the treatment of otoferlin gene-mediated hearing loss
30 August, 2022Sofinnova's Henrijette Richter talks to BioCentury about creating support networks for first-time CEOs